Inflammatory Arthritis

Selected Debates, Lectures, and Round Tables:

  • Biologics vs. small molecules in the management of rheumatoid arthritis
  • Induction and maintenance of remission: Are we there yet?
  • Is ACPA negative rheumatoid arthritis a different disease?
  • Eye and inflammatory arthritis
  • Lung in rheumatoid arthritis
  • Role of gut microbiome for autoimmune conditions
  • Incidence/risk of melanomatous and nonmelanomatous skin cancer with different biologics
  • How to diagnose and manage non-radiographic spondyloarthritis
  • How to manage the extra-articular manifestations of psoriatic arthritis
  • What next after the failure of anti-TNF agents in psoriatic arthritis
  • Management of co-morbidities
  • Incorporating biosimilars in daily practice


Selected Debates, Lectures, and Round Tables:

  • Biomarkers: Dreams and reality
  • Imaging: Usefulness in the diagnosis and treatment
  • The origin and management of pain in osteoarthritis
  • Metabolic syndrome and/or diabetes are risk factors for osteoarthritis: True or false?
  • The real challenges in osteoarthritis treatment: A multidisciplinary approach is the key to success
  • What have we learned about the advantages of meta-analyses?
  • Osteoarthritis and cardiovascular risk: Where are we?
  • The elderly patient with osteoarthritis: Alternative therapy
  • DMOAD clinical trials: Defining outcomes
  • Hip and hand osteoarthritis: Diagnostic and treatment update
  • Low back pain phenotyping patients
  • Improving patient outcome and care through lifestyle changes, medical devices, and technologies

Joint Session

  • Secondary osteoarthritis
  • How to improve arthritis patient education on disease and treatment